These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33981596)

  • 1. Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review.
    Yang Y; Ji J; Tang Z; Han B
    Front Oncol; 2021; 11():614965. PubMed ID: 33981596
    [No Abstract]   [Full Text] [Related]  

  • 2. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study.
    Liu L; Han B; Zhang Y; Lei M; Liu R; Lin Z; Jiao W; Zhang F; Fu R; Zhao X; Miao M; Zhang L; Wu D
    Bone Marrow Transplant; 2024 Oct; 59(10):1449-1457. PubMed ID: 39090437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?
    Huang LF; Li L; Jia JS; Yang Y; Lin SY; Meng FK; Zhang DH; He GS
    Transplant Cell Ther; 2022 Sep; 28(9):586.e1-586.e7. PubMed ID: 35609866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Geng C; Liu X; Chen M; Yang C; Han B
    Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
    Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
    Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of upfront haploidentical hematopoietic stem cell transplantation and salvage haploidentical hematopoietic stem cell transplantation after immunosuppressive therapy in children with acquired severe aplastic anemia - a multicenter study.
    Luo D; Qu Y; Wang D; Zhang B; Sun M; Xiong H; Lu J; Yang R; Zhao M; Liu H; Jiang H
    Front Immunol; 2024; 15():1384640. PubMed ID: 38720904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study.
    Liu L; Lei M; Fu R; Han B; Zhao X; Liu R; Zhang Y; Jiao W; Miao M; Zhang F; Zhang L; Wu D
    J Hematol Oncol; 2022 Aug; 15(1):105. PubMed ID: 35962406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
    Zhang Y; Li J; Li X; Geng Q; Xie Y; Zhang G; Wei M; Ma Y
    Syst Rev; 2024 Apr; 13(1):101. PubMed ID: 38576005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-
    Yao D; Tian Y; Li J; Li B; Lu J; Ling J; Zheng D; Yao Y; Xiao P; Meng L; Hu S
    Ther Adv Hematol; 2022; 13():20406207221134409. PubMed ID: 36324490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia.
    Zhao J; Ma L; Zheng M; Su L; Guo X
    Ann Hematol; 2023 Sep; 102(9):2565-2587. PubMed ID: 37442821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of Frontline Haploidentical Hematopoietic Stem Cell Transplantation and Salvage Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia].
    Xiao F; Liu Q; Fan D; Guo HX; Yan XQ; Zhao H; Liu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1683-1688. PubMed ID: 33067974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
    Jin Y; Li R; Lin S; Jia J; Yang Y; Zhang D; He G; Li J
    Ann Hematol; 2022 Nov; 101(11):2413-2419. PubMed ID: 36028583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
    Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
    Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia.
    Zhang Y; Huo J; Liu L; Shen Y; Chen J; Zhang T; Chen X; Pang A; Yang D; Zhang R; Ma Q; Zhai W; He Y; Wei J; Jiang E; Han M; Zheng Y; Feng S
    Front Immunol; 2022; 13():837335. PubMed ID: 35178053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.
    Yokota H; Miyao K; Sawa M; Terakura S; Kurahashi S; Ikoma Y; Imahashi N; Morishita T; Okamoto A; Kajiguchi T; Ono T; Narita T; Kanemura N; Ozeki K; Kojima Y; Naito K; Uchino K; Tomita A; Iida H; Imoto N; Kasahara S; Inagaki Y; Nishida T; Murata M
    J Hematol; 2024 Aug; 13(4):142-149. PubMed ID: 39247063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
    Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
    Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
    Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia.
    Zhao R; Ji D; Zhou Y; Qi L; Li F
    Int J Gen Med; 2024; 17():4025-4036. PubMed ID: 39290233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
    Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
    Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia.
    Liu L; Zhang Y; Jiao W; Zhou H; Wang Q; Jin S; Cai Y; Zhao L; Shangguan X; Liu Z; Xu J; Lei M; Yan X; Miao M; Wu D
    Leukemia; 2020 Dec; 34(12):3359-3369. PubMed ID: 32591644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.